DMRA

Damora Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

11.9%

Short % Float

11.7d to cover · Moderate squeeze

91.0%

Inst % Float

41.2M sh

Public Float

51/100

Dilution Score

High

179 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

51/100

HIGH

Inst: 91.04% · Top: None

Biotech Analytics

Biotech / Pharma

11.13

Dilution Risk: HIGHSqueeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications30

Dilution Risk51

Clinical Trials0

Short Interest50